Literature DB >> 28855975

Case Report: Unusual Manifestation of KIT Negative Systemic Mastocytosis.

Beatriz Cáceres-Nazario1, William Cáceres-Perkins2, David Tasso3, Elizabeth Calderón-Alicea2, Daniel Conde-Sterling3, Norma Arroyo-Portela2.   

Abstract

Aggressive systemic mastocytosis is a rare hematologic neoplastic disease that presents with a poor prognosis and low survival rate. It typically manifests with symptoms associated to mast cell release of bioactive substances, causing anaphylaxis, flushing, autonomic and hemodynamic instability, gastric distress and headache. Moreover, more than 95% of cases are related to a mutation in codon 816 of the KIT gene, located on human chromosome 4q12 which codes for a type III receptor tyrosine kinase. We present a 78 year-old Hispanic man diagnosed with the aggressive subtype of systemic mastocytosis, who had an atypical manifestation and a KIT negative variant. The diagnosis was confirmed based on pathologic and serologic findings which included mast cell infiltration of the spleen and bone marrow, malignant ascites and an unusually elevated serum tryptase.

Entities:  

Keywords:  KIT mutation; myeloproliferative disorders; systemic mastocytosis; tryptase

Year:  2016        PMID: 28855975      PMCID: PMC5573261     

Source DB:  PubMed          Journal:  Am J Hematol Oncol        ISSN: 1939-6163


  9 in total

1.  Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis.

Authors:  Todd M Wilson; Irina Maric; Olga Simakova; Yun Bai; Eunice Ching Chan; Nicolas Olivares; Melody Carter; Dragan Maric; Jamie Robyn; Dean D Metcalfe
Journal:  Haematologica       Date:  2010-12-06       Impact factor: 9.941

Review 2.  Mast cells and mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Blood       Date:  2008-08-15       Impact factor: 22.113

3.  Comprehensive mutational profiling in advanced systemic mastocytosis.

Authors:  Juliana Schwaab; Susanne Schnittger; Karl Sotlar; Christoph Walz; Alice Fabarius; Markus Pfirrmann; Alexander Kohlmann; Vera Grossmann; Manja Meggendorfer; Hans-Peter Horny; Peter Valent; Mohamad Jawhar; Martina Teichmann; Georgia Metzgeroth; Philipp Erben; Thomas Ernst; Andreas Hochhaus; Torsten Haferlach; Wolf-Karsten Hofmann; Nicholas C P Cross; Andreas Reiter
Journal:  Blood       Date:  2013-08-19       Impact factor: 22.113

4.  Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.

Authors:  Jason Gotlib; Hanneke C Kluin-Nelemans; Tracy I George; Cem Akin; Karl Sotlar; Olivier Hermine; Farrukh T Awan; Elizabeth Hexner; Michael J Mauro; David W Sternberg; Matthieu Villeneuve; Alice Huntsman Labed; Eric J Stanek; Karin Hartmann; Hans-Peter Horny; Peter Valent; Andreas Reiter
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

5.  Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

Authors:  Celalettin Ustun; Jason Gotlib; Uday Popat; Andrew Artz; Mark Litzow; Andreas Reiter; Ryotaro Nakamura; Hanneke C Kluin-Nelemans; Srdan Verstovsek; James Gajewski; Miguel-Angel Perales; Tracy George; Tsiporah Shore; Wolfgang Sperr; Wael Saber; Vamsi Kota; Akif Selim Yavuz; Vinod Pullarkat; John Rogosheske; William Hogan; Koen Van Besien; Hans Hagglund; Gandhi Damaj; Michel Arock; Hans-Peter Horny; Dean D Metcalfe; H Joachim Deeg; Steven Devine; Daniel Weisdorf; Cem Akin; Peter Valent
Journal:  Biol Blood Marrow Transplant       Date:  2016-04-27       Impact factor: 5.742

Review 6.  Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.

Authors:  Michel Arock; Peter Valent
Journal:  Expert Rev Hematol       Date:  2010-08       Impact factor: 2.929

7.  Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates.

Authors:  A Tefferi; R L Levine; K-H Lim; O Abdel-Wahab; T L Lasho; J Patel; C M Finke; A Mullally; C-Y Li; A Pardanani; D G Gilliland
Journal:  Leukemia       Date:  2009-03-05       Impact factor: 11.528

Review 8.  Diagnosis and management of mastocytosis: an emerging challenge in applied hematology.

Authors:  Peter Valent
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

Review 9.  KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.

Authors:  M Arock; K Sotlar; C Akin; S Broesby-Olsen; G Hoermann; L Escribano; T K Kristensen; H C Kluin-Nelemans; O Hermine; P Dubreuil; W R Sperr; K Hartmann; J Gotlib; N C P Cross; T Haferlach; A Garcia-Montero; A Orfao; J Schwaab; M Triggiani; H-P Horny; D D Metcalfe; A Reiter; P Valent
Journal:  Leukemia       Date:  2015-02-04       Impact factor: 11.528

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.